I didn't do any kind of comparison to other "enchanced" space company attendees. Hit on "enchanced", it will bring the full list of the others, and then see if they have abstracts. At the time I looked, Abstracts were not in.
When I initially looked at the space they had, and paired it with the ASCO agenda, I really believed they might have been presenting on an entire cancer Designation, as opposed to some sporadic case studies. It could very well be possible that they're done on specific cancers, all the data being in. Maybe there is a reason why AARC abstract only has data for 29 patients assessed in it (29 of the 40 Ph I assessed), and not ONE with Colon in it (unless they were the Several other cancers category). Maybe they're leaving room to showcase the 11 left out of the AARC abstract for an ASCO abstract, but they just haven't annouced it yet. Maybe they'll be a ASCO. SoS seems to believe it might be so. I'm going to be like Flip and wait for it before I say no, but as of today, they're not. :)
Market Data 
Markets 
AI
